Product Name | PJ-34 |
Description |
PARP inhibitor |
Purity | >98% (HPLC); NMR (conforms) |
CAS No. | 344458-15-7 |
Molecular Formula | C17H17N3O2•HCL•H2O |
Molecular Weight | 331.8 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Inhibitor |
Solubility | May be dissolved in DMSO (30 mg/ml) or water (20 mg/ml) |
Source | Synthetic |
Appearance | White to yellow solid. |
SMILES | CN(C)CC(=O)NC1=CC2=C(C=C1)NC(=O)C3=CC=CC=C32.Cl |
InChI | InChI=1S/C17H17N3O2/c1-20(2)10-16(21)18-11-7-8-15-14(9-11)12-5-3-4-6-13(12)17(22)19-15/h3-9H,10H2,1-2H3,(H,18,21)(H,19,22) |
InChIKey | UYJZZVDLGDDTCL-UHFFFAOYSA-N |
Safety Phrases |
Classification: Caution: Substance not yet fully tested. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection |
Cite This Product | PJ-34 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-366) |
Alternative Names | N-(6-Oxo-5,6-dihydrophenanthridin-2-yl)-N,Ndimethylacetamide . HCl |
Research Areas | Apoptosis, Cancer, Cancer Growth Inhibitors, PARP Inhibitors |
PubChem ID | 4858 |
Scientific Background | PJ-34 is a selective inhibitor of Poly (ADP-Ribose) polymerase (PARP). Studies have shown that the use of PJ-34 on severe inflammatory diseases, in particular experimental allergic encephalomyelitis (EAE) have contributed to a shift of the immune response from a pro-inflammatory Th1 to anti-inflammatory th2 phenotype (1). |
References | 1. Scott G., Kean R., Mikheeva., Fabis M., Mabley J.J. (2004) The Journal of Pharmacology and Exp. Therapeutics. 310(3): 1053-1061. |
Reviews
There are no reviews yet.